ENDRA Life Sciences EV/EBITDA Ratio 2011-2026 | NDRA

Annual EV/EBITDA Ratio ENDRA Life Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.785	0.0472	0.167	-0.675	0.831	-2.61	-0.5	-0.387	-0.826	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.831	-2.61	-0.526

EV/EBITDA Ratio of other stocks in the Diagnostics research industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	2.04	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	0.387	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	-134	-	-	$ 1.31 B	USA
DermTech DMTK	-0.68	-	-11.32 %	$ 2.94 M	USA
Quest Diagnostics Incorporated DGX	5.51	$ 202.62	-0.22 %	$ 22.5 B	USA
Celcuity CELC	-32.4	$ 87.02	-1.73 %	$ 4.07 B	USA
Akumin AKU	23.4	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	0.0391	$ 3.92	-8.62 %	$ 5.21 M	USA
Fulgent Genetics FLGT	-8.71	$ 18.8	0.62 %	$ 579 M	USA
Castle Biosciences CSTL	-227	$ 20.89	0.92 %	$ 606 M	USA
Aspira Women's Health AWH	-1.36	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-2.05	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	-0.496	-	-13.05 %	$ 7.29 M	USA
Oxford Immunotec Global PLC OXFD	-73.4	-	-	$ 562 M	Britain
Guardant Health GH	-38.2	$ 131.75	0.1 %	$ 16.5 B	USA
CareDx, Inc CDNA	-100	$ 24.01	4.53 %	$ 1.28 B	USA
Chembio Diagnostics CEMI	-1.86	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	0.000843	-	-	$ 9.42 M	Israel
Interpace Biosciences IDXG	3.62	$ 1.64	2.19 %	$ 7.26 M	USA
ICON Public Limited Company ICLR	20	$ 147.44	0.86 %	$ 11.6 B	Irlanda
Illumina ILMN	22.1	$ 165.39	2.75 %	$ 25.6 B	USA
HTG Molecular Diagnostics HTGM	-0.156	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	-4.15	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-13.6	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-2.67	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-0.932	-	0.12 %	$ 80.1 M	China
Lantheus Holdings LNTH	15.5	$ 104.01	-0.49 %	$ 7.02 B	USA
Charles River Laboratories International CRL	26.6	$ 190.51	1.6 %	$ 9.44 B	USA
PRA Health Sciences, Inc. PRAH	20.8	-	-	$ 10.7 B	USA
Medpace Holdings MEDP	30.7	$ 466.52	-0.18 %	$ 13.5 B	USA
Mettler-Toledo International MTD	627	$ 1 158.81	2.41 %	$ 23.9 B	Schweiz
Exact Sciences Corporation EXAS	-20.8	-	-	$ 19.8 B	USA
NeoGenomics NEO	-33.5	$ 11.2	0.4 %	$ 1.43 B	USA
Myriad Genetics MYGN	-1.79	$ 4.32	-0.23 %	$ 400 M	USA
National Research Corporation NRC	14.3	$ 18.42	-1.97 %	$ 412 M	USA
Natera NTRA	-112	$ 215.76	1.74 %	$ 29.5 B	USA
Pacific Biosciences of California PACB	-2.24	$ 1.37	4.5 %	$ 411 M	USA
Personalis PSNL	-4.87	$ 10.16	6.0 %	$ 907 M	USA
Koninklijke Philips N.V. PHG	17.1	$ 26.74	1.06 %	$ 25.4 B	Niderland
Senseonics Holdings SENS	-5.62	$ 7.26	1.04 %	$ 303 M	USA
QIAGEN N.V. QGEN	13.2	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	186	-	-	$ 2.69 B	USA
Biomerica BMRA	-6.24	$ 2.0	-2.44 %	$ 4.59 M	USA
Laboratory Corporation of America Holdings LH	8.7	$ 265.12	-0.39 %	$ 22.1 B	USA
Twist Bioscience Corporation TWST	-23.6	$ 81.5	7.0 %	$ 4.87 B	USA
Thermo Fisher Scientific TMO	19.3	$ 475.94	1.51 %	$ 179 B	USA
Trinity Biotech plc TRIB	-15.5	$ 0.67	3.57 %	$ 241 M	Irlanda
Motus GI Holdings MOTS	-0.0496	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	40.3	$ 9.28	1.98 %	$ 2.01 B	USA
Invitae Corporation NVTA	44.6	-	-	$ 21.2 M	USA